Author Correction: Circular RNA circ-PRKCI promotes cell proliferation and invasion by binding to microRNA-545 in gastric cancer
L. Wu, Y. Li, X.-M. Xu, X. Zhu Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Correction to: European Review for Medical and Pharmacological Sciences 2019; 23 (21): 9418-9426–DOI: 10.26355/eurrev_201911_19435–PMID: 31773680, published online on 15 November 2019.
After publication, the authors applied to change Figure 1E stating that “gastric cancer was observed from patients underlying response at Renmin Hospital of Wuhan University from March 2015 to March 2016. By the time of submission, the survival time of follow-up was only 2 years. From the 2-year follow-up data, we found that high expression of CIRC PRKCI was positively associated with a poor prognosis of GC patients”.
The authors claim that there is no serious change in the conclusion of the article.
There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
L. Wu, Y. Li, X.-M. Xu, X. Zhu
Author Correction: Circular RNA circ-PRKCI promotes cell proliferation and invasion by binding to microRNA-545 in gastric cancer
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 2
Pages: 346-346
DOI: 10.26355/eurrev_202201_27855